PALL, GELMAN SCIENCES $284 MIL. MERGER IS "MORE FAVORABLE" THAN PREVIOUS PACT WITH MEMTEC, GELMAN SAYS; DEAL BOLSTERS PALL'S LABORATORY PRODUCT OFFERINGS
This article was originally published in The Gray Sheet
Executive Summary
Microfiltration products firms Pall and Gelman Sciences took advantage of an escape clause in Gelman's merger deal with Memtec Ltd., announcing Oct. 28 a definitive agreement to merge in a stock transaction valued at $284 mil., or $33 per Gelman share.